Therapeutic Efficacy of Ivermectin as an Adjuvant in the Treatment of Patients with COVID-19 Study conducted at the Social Security Institute for Workers of the State of Chiapas, ISSTECH, Mexico


Authors : Alberto Cundapí Núñez; Gerardo Grajales Yuca; Jesús Miguel Leyva Cervantes; Ana Paola Rubiano Murcia; Marco Antonio Ordoñez Juárez; Jenner Josué Martínez

Volume/Issue : Volume 5 - 2020, Issue 7 - July

Google Scholar : http://bitly.ws/9nMw

Scribd : https://bit.ly/30yw7MH

DOI : 10.38124/IJISRT20JUL252

This document sets out the results of a study aimed at estimating the therapeutic efficacy of ivermectin as an adjuvant in the treatment of COVID-19 patients treated at the Specialty Hospital Vida Mejor of the Institute of Social Security for Workers of the State of Chiapas, ISSTECH, Mexico. Ivermectin as an adjuvant in the treatment of COVID-19 patients is more effective (92%) outpatient patients. In critical hospitalized and severe hospitalized patients, ivermectin had a significant impact, both in improving patients' health and decreasing lethality

Keywords : Ivermectin, COVID-19, Efficacy.

CALL FOR PAPERS


Paper Submission Last Date
30 - September - 2021

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe